FULC
Fulcrum Therapeutics Inc
3.80$
+2.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 1,930.9% | 638.8% | 846.3% | 382.1% | 341.1% | 396.7% | 346.0% | 373.9% | 687.9% | 1,329.4% | 1,298.9% | 86.3% | 5,666.1% | 2,028.3% | 2,402.9% | 58.3% | – | 21.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -1,830.9% | -538.8% | -746.3% | -282.1% | -241.1% | -296.7% | -246.0% | -273.9% | -587.9% | -1,229.4% | -1,198.9% | 13.7% | -5,566.1% | -1,928.3% | -2,302.9% | 41.7% | – | 78.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 1,930.9% | 638.8% | 846.3% | 382.1% | 341.1% | 396.7% | 346.0% | 373.9% | 687.9% | 1,329.4% | 1,298.9% | 2,710.4% | 5,666.1% | 2,028.3% | 2,402.9% | 2,181.3% | – | 21.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 644.5% | 247.7% | 287.4% | 138.9% | 110.5% | 148.2% | 170.3% | 204.2% | 398.1% | 561.7% | 772.4% | 1,478.8% | 3,682.4% | 1,103.1% | 1,228.1% | 1,132.5% | – | 12.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 675.2% | 257.5% | 287.4% | 138.9% | 114.8% | 152.6% | 174.8% | 191.9% | 415.1% | 589.7% | 859.8% | 4,189.2% | 3,905.1% | 1,173.1% | 1,312.4% | 3,255.5% | – | 12.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2,506.1% | -796.2% | -1,033.8% | -421.0% | -355.9% | -449.3% | -420.9% | -465.8% | -1,003.0% | -1,819.1% | -2,058.7% | -4,083.6% | -9,471.2% | -3,101.4% | -3,615.3% | -3,213.8% | – | 65.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.9% | 0.8% | 1.1% | 1.5% | 2.7% | 8.8% | 52.2% | 268.3% | 1,071.5% | – | – | 362.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2,460.3% | -784.3% | -1,026.1% | -419.4% | -355.0% | -448.5% | -419.8% | -464.3% | -1,000.3% | -1,810.3% | -2,006.6% | -3,815.3% | -8,399.7% | -2,702.6% | -3,164.3% | -2,842.3% | – | 69.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -17.3% | – | -0.6% | 0.4% | -12.3% | -2.7% | -1.3% | 26.5% | -365.7% | -1,071.5% | 59.7% | 53.9% | 362.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2,460.3% | -784.3% | -1,026.1% | -419.4% | -355.0% | -448.5% | -419.8% | -464.3% | -1,000.3% | -1,810.3% | -2,006.6% | -3,449.6% | -8,399.7% | -2,702.6% | -3,164.3% | -2,842.3% | – | 69.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2,434.3% | -768.6% | -1,003.8% | -403.6% | -343.3% | -433.1% | -407.2% | -452.0% | -979.6% | -1,774.4% | -1,967.8% | -4,094.7% | -8,207.8% | -2,638.2% | -3,094.3% | -2,783.9% | – | 69.7% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.